DIRS.INFO The most relevant business & tech news

Here's a rapid-fire update on all 32 stocks in Jim Cramer's Charitable Trust, the portfolio we use for the CNBC Investing Club. AMD shares have caught a bid in recent days, but they're still cheap considering the growth of its AI processors. Broadcom : Investors who don't own any Broadcom yet should consider starting a position here, Jim said. Although it's tempting to offload shares, Jim said to stick with Honeywell for now because there's huge value in individual businesses like aerospace. There's little negative to say about this portfolio stock.

Persons: Jim Cramer's, Jim, Apple, haven't, it's, that's, he'll, Bob Iger, Bob Chapek, Larry Ellison, Biogen, Eli Lilly, Lowe's, Vimal Kapur, We'd, Linde, Lilly, Morgan Stanley, Goldman Sachs, It's, Jensen Huang, Kamala Harris, Republican Donald Trump, CrowdStrike, Palo, — we're, we're, Brian Niccol, Sands, Stanley Black, Decker, Wells, Charlie Scharf's, Jim Cramer, Angela Weiss Organizations: Jim Cramer's Charitable Trust, CNBC, Club, Abbott Laboratories, Abbott Labs, AMD, Amazon, Web, Broadcom, VMWare, Federal Reserve, Costco Wholesale, Coterra, DuPont, New York Times, Oracle, GE Healthcare, GE, Honeywell, Linde, Microsoft, Nvidia, Republican, Palo Alto Networks, Palo, Procter & Gamble, Procter, Gamble, Constellation Brands, Modelo, Stanley, TJX, Marshalls, Jim Cramer's Charitable, Traders, New York Stock Exchange, AFP, Getty Locations: Nvidia's, San Francisco, China, Dover, United States, industrials, OpenAI, Palo Alto, Wells Fargo

☆ Digital health company Noom to offer compounded GLP-1 drug through new weight loss program
▼ + stars: | 2024-09-12 | by ( Ashley Capoot | In | ) www.cnbc.com time to read: +5 min

Digital health company Noom on Thursday announced it will offer a compounded GLP-1 drug as part of a new weight loss product that starts at $149. Noom has offered weight loss programs for years, and consumers can already try to access those branded medications through its platform. Compounded GLP-1 medications are typically much cheaper than their branded counterparts. Most insurance plans cover GLP-1s when they are used to treat diabetes, but coverage of the weight loss drugs is less widespread. Consumers can get started with the Noom GLP-1 RX program by filling out an intake form on the website.

Persons: Wegovy, Noom, Geoff Cook, Cook, Dr, Adonis Saremi, They'll Organizations: CNBC, U.S . Food, Drug Administration, FDA Locations: U.S, United States

☆ JPMorgan says this new player in the GLP-1 market could rally 45%
▼ + stars: | 2024-09-11 | by ( Brian Evans | ) www.cnbc.com time to read: +2 min

JPMorgan thinks Viking Therapeutics could be the next big name in the GLP-1 boom. Investors are awaiting more details about the oral version, expected in early November, as a possible catalyst for the stock. VKTX YTD mountain Viking Therapeutics stock. Some patients who take these popular obesity drugs suffer nausea and gastrointensinal effects that force them to stop treatment. Oral drugs also tend to be cheaper and easier to manufacture.

Persons: GLP, Eli Lilly, Viking, Hardik Parikh, Parikh, Wegovy, Eli Lilly's Zepbound Organizations: JPMorgan, Viking, Therapeutics, Novo Nordisk, Investors, Viking Therapeutics

☆ Here are Wednesday's biggest analyst calls: Nvidia, Apple, Spotify, Arm, Robinhood, Alphabet, Shopify, Disney & more
▼ + stars: | 2024-09-11 | by ( Michael Bloom | ) www.cnbc.com time to read: +6 min

Here are Wednesday's biggest calls on Wall Street: Goldman Sachs downgrades Morgan Stanley to neutral from buy Goldman said it sees better value elsewhere than Morgan Stanley. Goldman Sachs upgrades Evercore to buy from neutral Goldman said the investment banking firm is "best in class." JPMorgan reiterates Nvidia as overweight JPMorgan said stocks such as Nvidia are "strong beneficiaries in the emerging AI arms race." Morgan Stanley reiterates Arm as a top pick Morgan Stanley said it's sticking with its overweight rating on the semiconductor chip company. Bank of America reiterates Apple as buy Bank of America said it's standing by its buy rating on shares of Apple.

Persons: Goldman Sachs downgrades Morgan Stanley, Goldman, Morgan Stanley, Goldman Sachs, Rosenblatt, Canaan, Jefferies, Williams, Guggenheim, it's, orals, it's bullish, Bernstein, Robinhood, Wells, Shopify, Truist, Wolfe Organizations: NASDAQ, JPMorgan, Viking Therapeutics, Citi, Apollo Global Citi, APO, U.S, " Bank of America, Novartis, Bank of America, Nvidia, Apple, Spotify, Disney, AES, ~$ Locations: Canaan, Williams, Sonoma, 2030E

☆ The next big market for weight-loss drugs: children
▼ + stars: | 2024-09-11 | by ( Shubhangi Goel | ) www.businessinsider.com time to read: +3 min

Novo Nordisk's American rival, Eli Lilly, has also been testing obesity-beating drugs for children as young as six. Wegovy and similar drugs for weight loss have become a huge business. The drugs' success has made Novo Nordisk the most valuable company in Europe. AdvertisementChildhood obesityAn FDA approval on weight loss drugs for children could open up a new market for Novo Nordisk. In June, US Sen. Bernie Sanders announced that Novo Nordisk CEO Lars Jørgensen would testify before the committee on September 24 at a hearing focusing on the prices that Novo Nordisk charges Americans for their drugs, Ozempic and Wegovy.

Persons: —, Saxenda, Novo, Claudia Fox, Eli Lilly, Goldman Sachs, Wegovy, Sen, Bernie Sanders, Lars Jørgensen, Sanders Organizations: Service, BMI, Business, FDA, Financial Times, Novo Nordisk, Centers for Disease Locations: Madrid, Europe

The rate of weight loss with the experimental pill, called amycretin, appears to be more rapid than what’s seen for other drugs. “It’s roughly double the weight loss rate seen with current GLP-1 agonists and approaching procedural or surgical-level outcomes,” said Dr. Christopher McGowan, a gastroenterologist who runs a weight loss clinic in North Carolina. McGowan said that while the weight loss was significant, he still has concerns about how fast people lost weight. “While losing weight is seemingly the end goal, how that weight is lost matters,” he said. Spratt said she would like to know how much of the weight loss came from fat compared with muscle.

Persons: “, ”, Christopher McGowan, ” Dr, Susan Spratt, Spratt, haven’t, Martin Lange, Lange, McGowan, ” McGowan Organizations: Novo Nordisk, European Association for, Diabetes, Population Health Management, Duke Health Locations: Novo, Spain, North Carolina, semaglutide, Wegovy, It’s

The findings bring the phenomenon — and the controversy — of the latest new and powerful weight loss drugs to the youngest age group yet. The new trial looked at liraglutide, the active ingredient used in two of Novo Nordisk’s older GLP-1 drugs: Saxenda, a weight loss drug, and Victoza, a diabetes drug. So instead of looking at overall weight loss like in adult studies, they decided to focus more on BMI, which takes into account both weight and height. A spokesperson for Novo Nordisk said that it has submitted an application to the Food and Drug Administration to expand the approval of liraglutide for weight loss in children ages 6 to 11. Is 6 too young for a weight loss drug?

Persons: Roy Kim, “, ” Kim, Claudia Fox, Fox, Eli Lilly, ”, liraglutide, ” Fox, Sarah Armstrong, ” Armstrong, comorbidities, it’s, ” Wegovy, Zepbound, Shauna Levy, ” Levy Organizations: New England, of Medicine, Novo Nordisk, Cleveland Clinic, Centers for Disease Control, University of Minnesota, BMI, Food and Drug Administration, American Academy of Pediatrics, Duke University, Tulane Bariatric Center Locations: liraglutide, Ozempic, Ohio, U.S, New Orleans

☆ Multiple myeloma gets new attention after Patti Scialfa, Bruce Springsteen's wife and bandmate, reveals diagnosis
▼ + stars: | 2024-09-10 | by ( Https | Media-Cldnry.S-Nbcnews.Com Image Upload Newscms Aria-Bendix-Byline-Jm.Jpg | Aria Bendix | ) www.nbcnews.com time to read: +5 min

The news that Patti Scialfa, Bruce Springsteen’s wife and bandmate, has multiple myeloma is bringing attention to the rare blood cancer. Multiple myeloma affects plasma cells, a type of white blood cell produced in the bone marrow. “Myeloma treatment is a marathon,” said Dr. Manni Mohyuddin, a multiple myeloma specialist at the University of Utah’s Huntsman Cancer Institute. Multiple myeloma is twice as common among Black people than white people in the U.S., and mortality rates among Black Americans are twice as high. In many cases, people with multiple myeloma are still able to pursue normal activities.

Persons: Patti Scialfa, Bruce Springsteen’s, Bruce Springsteen, ” Scialfa, that’s, Scialfa, Springsteen, —, ”, Manni, Joseph Mikhael, Mikhael, ” Mohyuddin, don’t, Mohyuddin, Orange, ” Mikhael, Dr, Mansi Shah, oncologist, ” Shah, we’ve Organizations: Variety, Toronto Film, University of Utah’s Huntsman Cancer Institute, U.S, International, Firefighters, Rutgers Cancer Institute, RWJBarnabas Health Locations: U.S, New Jersey

☆ Early puberty may be linked to a common chemical used in personal care products
▼ + stars: | 2024-09-10 | by ( Linda Carroll | Linda Carroll Is A Regular Health Contributor To Nbc News. She Is Coauthor Of | The Concussion Crisis | ) www.nbcnews.com time to read: +5 min

Shaw, a co-senior author of the new study, acknowledged a link between early puberty and excess weight in young girls. “I do think it plays a role, but in my practice, it’s not just those who are overweight or obese who are having early puberty,” she said. But children were most likely to be exposed to only one of them: musk ambrette, according to the report, published in Endocrinology. Musk ambrette is widely used in inexpensive or counterfeit fragrances and other scented personal care products, Shaw said. She was surprised that phthalates, which have been linked to early puberty, didn’t come up in the research.

Persons: Natalie Shaw, Shaw, “, it’s, ”, ” Shaw, haven’t, Apisadaporn, didn’t, Jasmine McDonald, McDonald, ” McDonald Organizations: National Institute of Environmental Health Sciences, Harvard, of Public Health, UCLA, Columbia University Mailman School of Public Health Locations: Durham , North Carolina, Chan, New York City

☆ Regular exercise may lead to healthier belly fat, study finds
▼ + stars: | 2024-09-10 | by ( Kaitlin Sullivan | Kaitlin Sullivan Is A Contributor For Nbcnews.Com Who Has Worked With Nbc News Investigations. She Reports On Health | Science | ) www.nbcnews.com time to read: +4 min

Belly fat tends to get a bad rap, but new research shows that one kind of belly fat can be healthier than others — provided you’re willing to get moving. The fat, the study found, essentially behaved differently in people with the same percentage of body fat, based on their long-term exercise habits. Regular exercisers had less rigid or fibrous fat tissue, which allows fat cells beneath the skin to expand to store fat, one of the body’s primary sources of energy. While expanding fat cells may sound like a bad thing, it’s actually better for health than having inflexible fat tissue. Another indication of this was that they had more proteins involved with fat metabolism in their fat tissue, the study found.

Persons: —, ”, Jeffrey Horowitz, Horowitz, exercisers, Jaime Almandoz, Aayush, Rutgers Robert Wood, ” Visaria Organizations: University of Michigan School of Kinesiology, BMI, UT Southwestern Medical Center, Rutgers, Rutgers Robert Wood Johnson Medical School Locations: exercisers, nonexercisers, Dallas

☆ Exercise may help you store fat better, new research suggests
▼ + stars: | 2024-09-10 | by ( Madeline Holcombe | ) edition.cnn.com time to read: +4 min

CNN —Exercise doesn’t just help you lose fat. Exercise is important for many facets of health, and it may even impact how fat is stored, a new study showed. “Fat tissue itself is very, very important for health,” he said. The goal isn’t more fat tissue, but better capacity to store it, Horowitz said. Fat tissue is supposed to be stored under the skin, and if it can’t go there it’s going to go other places such as your liver, heart or pancreas, he added.

Persons: ”, Jeffrey Horowitz, Horowitz, ” Horowitz, Andrew Freeman, Freeman, “, ” Freeman Organizations: CNN’s, CNN, University of Michigan, Jewish Health Locations: kinesiology, Denver

☆ Weekend sleep-ins may benefit heart health, research finds
▼ + stars: | 2024-08-30 | by ( Kristen Rogers | ) edition.cnn.com time to read: +6 min

New research suggests doing so may even benefit your heart health, amounting to a 19% lower risk of developing heart disease, according to a research abstract published Thursday. Sleeping in on weekends may lower your risk of developing heart disease later in life, new research suggests. Other experts suggested people still address inconsistent sleep patterns since it can affect more than just heart health. “Sleep is restorative and a key component of heart health preservation.”There are still other unanswered questions, Gulati said: Is there a threshold of too much sleep on the weekend? “To promote heart health, it’s recommended to aim for at least 7 hours of sleep each night and maintain a consistent sleep pattern,” Goldberg said.

Persons: ”, Yanjun, Elena Noviello, Nieca Goldberg, University’s, Goldberg wasn’t, catchup, Dr, Nour Makarem, wasn’t, Martha Gulati, Barbra Streisand, Makarem, ” Makarem, sleep’s, “, ” Goldberg, Gulati, ” Gulati, it’s Organizations: CNN, European Society of, State Key Laboratory, Infectious, National Center for Cardiovascular, Fuwai Hospital, Getty, University’s Grossman School of Medicine, Columbia University’s Mailman, of Public Health, Sinai Medical Center Locations: Beijing, United Kingdom, York City, New, Cedars, Los Angeles

Robert F. Kennedy Jr., left, waves to the crowd as former President Donald Trump speaks at a campaign rally in Glendale, Arizona on August 23. Ross D. Franklin/APFormer President Donald Trump addressed supporters at a rally in Glendale, Arizona, Friday, where he was joined by Robert F. Kennedy Jr., who suspended his own presidential campaign just hours earlier. However, Harris did mention the border and criticized Trump’s role in tanking a bipartisan border bill earlier this year. RFK Jr. could be appointed to a health panel: When suspending his presidential campaign, Kennedy suggested that he could join a potential second Trump administration in a role that would oversee a health care portfolio. Alejandra Jaramillo and Michelle Watson contributed to this post.

Persons: Robert F, Kennedy Jr, Donald Trump, Ross D, Trump, Harris, Kamala Harris, Trump’s, John F, Kennedy, ” Kennedy, that’s, CNN’s Aaron Pellish, Kate Sullivan, Kristen Holmes, Alejandra Jaramillo, Michelle Watson Organizations: Franklin, Democratic National Convention, RFK Jr Locations: Glendale , Arizona, tanking, Glendale

☆ New Covid shots are coming available. Here’s what experts say about when to get yours
▼ + stars: | 2024-08-23 | by ( Brenda Goodman | ) edition.cnn.com time to read: +5 min

CNN —Newly updated vaccines against Covid-19 will be in pharmacies soon, just as the US is experiencing a surge of infections. Experts say it depends on your health, whether you’ve recently had Covid-19, which vaccine you plan to get and when it’s convenient for you. For that reason, he’s going to hold off on getting the updated shot. Ranney noted that the updated mRNA shots from Pfizer and Moderna will probably be available first, with Novavax’s vaccine coming in a few weeks. “The reality is that we’ve had waves of Covid every summer for the last few years, and so I think we have to kind of do a reset or rethink about how we’re doing Covid vaccine delivery,” Hotez said.

Persons: you’ve, “ It’s, ”, Carlos del Rio, “, You’ve, Del, Paul Offit, Megan Ranney, Ranney, Peter Chin, “ I’m, I’m, you’re, ” Chin, Hong, Dr, Sanjay Gupta, Peter Hotez, ” Hotez Organizations: CNN, Covid, Emory University, Vaccine Education, Children’s Hospital of Philadelphia, Food, Yale School of Public Health, Pfizer, Moderna, University of California, ”, CNN Health, Texas Children’s Hospital Locations: Del Rio, San Francisco, Texas

☆ The breakfast a top nutrition scientist eats for gut health — plus the common foods he avoids
▼ + stars: | 2024-08-23 | by ( Serafina Kenny | ) www.businessinsider.com time to read: +3 min

Read previewA top gut-health expert shared his go-to breakfast with Business Insider and common breakfast items that he no longer eats. So Dr. Tim Spector, a British epidemiologist, gut health expert, and cofounder of the science and nutrition company ZOE, has a go-to breakfast combination that he eats every morning that is balanced and gut-healthy. "I used to have granola with some skim milk, orange juice, and tea, and I thought that was a super healthy breakfast," he said. But since swapping to a more gut-friendly breakfast, Spector has found that he stays full "right through to lunch," and his energy levels are consistent all morning. A 2020 review of studies published in the journal Food Frontiers suggested that polyphenols are indeed good for gut health, and also that they help prevent chronic diseases such as diabetes, obesity, and cardiovascular diseases.

Persons: —, Tim Spector, ZOE, Spector, Heidi Tissenbaum, he's Organizations: Service, Business, Stanford University Locations: British

Several analysts raised their ratings and price targets on Starbucks a day after news that Chipotle CEO would take over at the coffee chain. Starbucks shares rallied on the news, while Chipotle shares fell. He also lowered his price target on shares to $685 from $750, which implies just 6% upside from Monday's close. Chipotle shares pulled back of 7% comes as decelerating trends and a sector rotation already impacted Chipotle's multiple. Since Niccol took the position of CEO in 2018, Chipotle shares surged more than 770%.

Persons: Bernstein, Fatima Boolani, Boolani, — Hakyung Kim, Eli Lilly Eli Lilly's, Berenberg, Lilly, Kerry Holford, " Holford, Morgan Stanley, Keith Weiss, Weiss, Hakyung Kim, Brian Niccol's, Danilo Gargiulo, Gargiulo, Niccol, Chipotle, Laxman Narasimhan, Brian Niccol, Baird, David Tarantino, Fred Imbert Organizations: CNBC, Citi, Palo Alto, Palo Alto Networks, pharma, Intuit, Starbucks, Deutsche Bank, SBUX Locations: Tuesday's

☆ Global cancer deaths among men projected to increase by 93% by 2050, study finds
▼ + stars: | 2024-08-12 | by ( Jamie Gumbrecht | ) edition.cnn.com time to read: +3 min

CNN —Cancer cases and deaths among men are expected to surge by 2050, according to a study published Monday, with large increases among men age 65 and older. The study projects overall cancer cases among men will increase from 10.3 million in 2022 to 19 million in 2050, an increase of 84%. Cancer deaths were projected to rise from 5.4 million in 2022 to 10.5 million in 2050, an increase of 93%. Countries with a lower-income and life expectancy are also projected to see larger increases in cancer deaths in men. Just as in 2022, lung cancer is projected to be the leading cause of cancer and cancer deaths in men in 2050.

Persons: They’re, Dr, Sanjay Gupta, ”, William Dahut, CNN’s Jacqueline Howard Organizations: CNN, Cancer, CNN Health, American Cancer Society Locations: Australia, Africa, Europe

☆ These low-volatility stocks have a winning record and are attractively valued
▼ + stars: | 2024-08-11 | by ( Pia Singh | In | ) www.cnbc.com time to read: +4 min

These stocks have low share price volatility over the past five years, and their total return — including share price gains and dividends — are greater than the S & P 500's over the past five years. Take a look at the names below: Health-care companies Amgen , UnitedHealth Group and AbbVie are among the names with low volatility and strong returns in recent years. Pharmaceutical company AbbVie's roughly 262% gain over the past five years is the highest of the stocks in the group. Amgen's share price has a 5-year total return of 104%, making it a steady grower, but still the slowest of the list. Other stocks with low volatility and attractive valuations include automotive replacement parts retailer AutoZone and insurance company Aflac .

Persons: Stocks, They're, Morgan Stanley, Wells, Mohit Bansal, TD Cowen, Kannan Venkateshwar, — CNBC's Christopher Hayes Organizations: CNBC, UnitedHealth, Pharmaceutical, Morgan Stanley Wealth Management, Humira, Barclays, Mobile

☆ A man lost 100 pounds by ditching restrictive diets that left him miserable. He shared 2 key lessons he learned about fat loss.
▼ + stars: | 2024-08-10 | by ( Kim Schewitz | ) www.businessinsider.com time to read: +4 min

Read previewBenji Xavier lost 100 pounds in just over a year by ditching fad diets. His experience reflects how restrictive diets don't equal long-term weight loss. It was then that he decided to embark on a second weight loss journey, but this time with his health and sustainability as the focus. He shared the two key lessons he learned on his weight loss journey. This approach is sometimes called the 80/20 rule, and is endorsed by dietitians as a sustainable approach to both weight loss and overall health.

Persons: —, Benji Xavier, He's, Xavier, didn't Organizations: Service, Business, CDC, dietitians Locations: New Jersey

☆ A dietitian who researches ultra-processed foods mostly avoids them. Here are her 3 favorite healthy, quick snacks.
▼ + stars: | 2024-08-10 | by ( Kim Schewitz | ) www.businessinsider.com time to read: +3 min

Read previewA dietitian whose research on the potential harms of ultra-processed foods has led her to eat fewer of them shared her three favorite quick, minimally processed snacks with Business Insider. "I try and lean on whole foods for snacks," Patel said. Here are the healthy, quick snacks Patel has on hand to help her avoid reaching for UPFs. Related storiesNuts are whole foods, containing health fats as well as some protein, and require little to no preparation or cooking to eat. But be mindful of how much you eat because despite being nutritionally dense, these snacks can be quite high in calories, Patel said.

Persons: —, Linia Patel, Patel Organizations: Service, Business, University of Milan, Global Public Health Locations: Italy

☆ In New Zealand, Māori are using Indigenous knowledge to combat climate change
▼ + stars: | 2024-08-10 | by ( Alaa Elassar | ) edition.cnn.com time to read: +18 min

It’s that “interconnectedness” that makes Māori ideal stewards of Aotearoa New Zealand, Parkin-Rae says. Whenua (Land)The work at Oaro River is part of a reforestation and predator control project led by Te Rūnanga o Kaikōura, a Māori tribal council in Kaikōura. Thomas Kahu, left, and Wiremu Stone are both descendants of Paikea the whale rider and work for Whale Watch Kaikōura. A Whale Watch Kaikōura boat full of tourists viewing sperm whales off the coast of South Island, New Zealand. Alaa Elassar/CNN“Incorporating te ao Māori (the Māori world) into our work is valuable to all of Aotearoa.

Persons: , New Zealand CNN — Justin Parkin, Rae, Te Waipounamu, Tamati, ” Wikiriwhi, Parkin, Justin Parkin, Alaa Elassar, Ngāti, Ngāi Tahu, “, ”, –, Te, Rawiri, kawau, toto, ā roto, it’s, ” Parkin, Thomas Kahu, Kahu, Tim Clayton, Corbis, ” Kahu, Māori, Wiremu Stone, Takoko, ” Takoko, ” Rangi, Daniel Gaussen, Aoraki Mackenzie, Sanka, ” Gaussen, CNN Mikey Ratahi, ” Ratahi, Gaussen, ” Kaitiaki, Kaikōura, Elassar, tangata whenua, don’t, it’ll Organizations: , New Zealand CNN, New Zealand, CNN, CNN Aotearoa New Zealand’s Ministry, Environment, Aotearoa New Zealand, Rawiri Manawatu, Manawatu, Aotearoa New, Whale Watch, Aotearoa New Zealand’s Department of Conservation, CNN Whale Watch, Conservation International Aotearoa, Pacific Whale Fund, Ocean Initiative, Aoraki, Sky Reserve, Southern, Sky Resource, University of Canterbury, Ministry Locations: , New Zealand, New, Māori, Aotearoa, Alaa, CNN Aotearoa, Ngāi, Aotearoa New, Oaro, Te Rūnanga, Kaikōura, Rūnanga, ” Moana, Aotearoa New Zealand, South Island , New Zealand, wonderment, Mackenzie, Lake Takapō, Mana, Wai, Zealanders, “

☆ A man lost 100 pounds and kept them off by making two simple lifestyle changes
▼ + stars: | 2024-08-08 | by ( Kim Schewitz | ) www.businessinsider.com time to read: +7 min

"I lost weight, but it wasn't in the healthiest way. AdvertisementXavier lost 100 pounds in high school on a restrictive diet, but it was "unsustainable," he said. Benji Xavier lost 100 pounds by making healthier versions of his favorite foods at home. AdvertisementXavier has maintained his weight loss by making healthy lifestyle changes. He has "cheat days," and eats whatever he wants on holiday without feeling guilty because he knows he'll return home to a healthy lifestyle.

Persons: —, Benji Xavier, Xavier, He's, unconfident, It's, he'll, it's, I'm Organizations: Service, Business, Centers for Disease Control, CDC Locations: New Jersey

☆ Eli Lilly's blowout quarter should quiet investor concerns about the stock
▼ + stars: | 2024-08-08 | by ( Kevin Stankiewicz | ) www.cnbc.com time to read: +11 min

Eli Lilly on Thursday reported a home-run quarter fueled by sales of its blockbuster obesity and diabetes drugs, quieting any lingering investor concerns in the stock. Eli Lilly Why we own it: Eli Lilly's best-in-class drugs should enable growth above the industry average for many years to come. The report left little doubt that Eli Lilly's best days are ahead, driven by the growth of GLP-1s. It's really early" for Zepbound, Eli Lilly CEO David Ricks said in a CNBC interview Thursday. But the good news is Eli Lilly's multibillion dollar investments to expand manufacturing capacity are paying off.

Persons: Eli Lilly, Eli Lilly's, Zepbound, Jim Cramer, Lilly, David Ricks, It's, We're, Eli Lilly hasn't, Novo, spooked Lilly, Gordon Brooks, it's, Ricks, Brooks, Verzenio, —, didn't, Jim Cramer's, Jim, George Frey Organizations: Revenue, LSEG, Novo Nordisk, Biogen, Merck, Pfizer, CNBC, Food and Drug Administration, Viking Therapeutics, Novo Nordisk —, FDA, RTP, Bloomberg, Getty Locations: Eisai, U.S, GLP, Roche, it's, Indianapolis, North Carolina, Europe, Germany, Provo , Utah

☆ Eli Lilly's second quarter eases Zepbound pricing fears and suggests it's making headway in weight loss race
▼ + stars: | 2024-08-08 | by ( Christina Cheddar Berk | In | ) www.cnbc.com time to read: +5 min

Lilly's shares are up more than 7% on the news. LLY YTD mountain Eli Lilly shares year to date. The first followed positive reports from rivals that showed they were making progress in developing their own weight loss drugs . However, sales rose 59% for Mounjaro quarter over quarter and were up 140% for Zepbound as Lilly saw better pricing. Meanwhile, analysts see several events on the horizon that could further boost Lilly's shares in coming months.

Persons: Eli Lilly, Bansal, Lilly, Carter Gould, Lilly's headwinds, Novo's, Wells Fargo's Bansal, Evan David Seigerman, Chris Schott, Schott, Lilly's Organizations: Novo Nordisk, Wells, Barclays, Nordisk, BMO Capital Markets, Food and Drug Administration Locations: Wells Fargo, Lilly's, Wednesday's

☆ If you invested $1,000 in drugmaker Eli Lilly 10 years ago, here's how much money you'd have now
▼ + stars: | 2024-08-08 | by ( Cheyenne Devon | ) www.cnbc.com time to read: +2 min

One of the world's most valuable drug manufacturers by market capitalization reported its second-quarter earnings results Thursday, and they were impressive. Zepbound was approved Nov. 8 by the U.S. Food and Drug Administration as a treatment for weight management and obesity, according to Eli Lilly. In its first full quarter in the U.S. market, Zepbound brought in $517.4 million in revenue, Eli Lilly reported in April. "We just see unbelievable demand, and we're not even trying that hard to promote this drug," Eli Lilly CEO David Ricks told CNBC during a "Squawk Box" interview Thursday. And drug manufacturers such as Eli Lilly and Novo Nordisk, the pharmaceutical company that makes Ozempic and Wegovy, are racing to meet that demand.

Persons: you've, Eli Lilly, it's, Zepbound, we're, David Ricks, Morgan Stanley's Organizations: U.S . Food, Drug Administration, CNBC, Centers for Disease Control, Pew Research Center, Novo Nordisk Locations: U.S, United States

Search resuls for: "Obesity"

25 mentions found